Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 CAD | -2.48% | -0.63% | -53.13% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.13% | 19.25M | |
+53.02% | 63.85B | |
-2.35% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.45% | 26.52B | |
-21.50% | 18.69B | |
+2.71% | 12.73B | |
+22.24% | 12.11B | |
+27.75% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- RBC Cuts Price Target on Aptose Biosciences to $23 From $40, Keeps Outperform Rating, Speculative Risk Qualifier